Dyslipidemia is a classic risk factor for cardiovascular disease and is associatedwith VC.17,37 Inhibition of MR did not alter serum levels of lipid markersbut the influence of dyslipidemia in the progression of CC was confirmed. Here, NR3C2 is linked to metabolic syndrome.